Eitan Fleischman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eitan Fleischman has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Aaron Fleischman
Department of Biomedical Engineering, Lerner Research Institute, The Cleveland Clinic, United States of America
1 shared publication - Akil H. Hutchinson
Internal Medicine, Newyork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, USA
1 shared publication Chathula Kumarasinghe
Internal Medicine, Newyork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, USA
1 shared publication- D. Geoffrey Vince
Department of Biomedical Engineering, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, USA; Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, USA
1 shared publication - David L. Wilson
Department of Biomedical Engineering, Case Western Reserve University , 10900 Euclid Avenue, Cleveland, OH 44106
1 shared publication - David S. Prabhu
Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, 44106, USA
1 shared publication
Latest Publications
- Open Access
- 27 December 2020
- Published by Springer Nature in Cureus
- Vol. 12 (12)
The Indirect Costs of the SARS-CoV-2 Pandemic: A Case of Severe Malaria in Brooklyn
Severe malaria due to the infection of Plasmodium falciparum is a critical infection that may lead to multisystem abnormalities if not promptly and adequately treated. We present a case of severe malaria in a patient recently repatriated from Conakry, Guinea, West Africa, marooned during the recent coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While the direct costs of the SARS-CoV-2 pandemic and its indirect effect on neighboring industries have been analyzed, the indirect costs of other ailments in medicine have yet to be fully established. This case explores the ramifications of the SARS-CoV-2 pandemic on what would otherwise have been routine prophylaxis of malaria in a traveler. Given the pandemic, the healthcare industry has had fundamental changes that have impacted access to healthcare, particularly in the outpatient setting.
- 27 December 2020
- Published by Springer Nature in Cureus
- Vol. 12 (12)
Open AccessThe Indirect Costs of the SARS-CoV-2 Pandemic: A Case of Severe Malaria in Brooklyn
Severe malaria due to the infection of Plasmodium falciparum is a critical infection that may lead to multisystem abnormalities if not promptly and adequately treated. We present a case of severe malaria in a patient recently repatriated from Conakry, Guinea, West Africa, marooned during the recent coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While the direct costs of the SARS-CoV-2 pandemic and its indirect effect on neighboring industries have been analyzed, the indirect costs of other ailments in medicine have yet to be fully established. This case explores the ramifications of the SARS-CoV-2 pandemic on what would otherwise have been routine prophylaxis of malaria in a traveler. Given the pandemic, the healthcare industry has had fundamental changes that have impacted access to healthcare, particularly in the outpatient setting.
- 29 May 2020
- Published by Springer Nature in Current Cardiology Reports
- Vol. 22 (7) , 1-15
Artificial Intelligence in Intracoronary Imaging
Purpose of Review This paper investigates present uses and future potential of artificial intelligence (AI) applied to intracoronary imaging technologies. Recent Findings Advances in data analytics and digitized medical imaging have enabled clinical application of AI to improve patient outcomes and reduce costs through better diagnosis and enhanced workflow. Applications of AI to IVUS and IVOCT have produced improvements in image segmentation, plaque analysis, and stent evaluation. Machine learning algorithms are able to predict future coronary events through the use of imaging results, clinical evaluations, laboratory tests, and demographics. Summary The application of AI to intracoronary imaging holds significant promise for improved understanding and treatment of coronary heart disease. Even in these early stages, AI has demonstrated the ability to improve the prediction of cardiac events. Large curated data sets and databases are needed to speed the development of AI and enable testing and comparison among algorithms.
- 29 May 2020
- Published by Springer Nature in Current Cardiology Reports
- Vol. 22 (7) , 1-15
Artificial Intelligence in Intracoronary Imaging
Purpose of Review This paper investigates present uses and future potential of artificial intelligence (AI) applied to intracoronary imaging technologies. Recent Findings Advances in data analytics and digitized medical imaging have enabled clinical application of AI to improve patient outcomes and reduce costs through better diagnosis and enhanced workflow. Applications of AI to IVUS and IVOCT have produced improvements in image segmentation, plaque analysis, and stent evaluation. Machine learning algorithms are able to predict future coronary events through the use of imaging results, clinical evaluations, laboratory tests, and demographics. Summary The application of AI to intracoronary imaging holds significant promise for improved understanding and treatment of coronary heart disease. Even in these early stages, AI has demonstrated the ability to improve the prediction of cardiac events. Large curated data sets and databases are needed to speed the development of AI and enable testing and comparison among algorithms.